These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2714336)

  • 21. Multiple mucosal biopsies and postoperative urinary cytology in patients with bladder cancer.
    Gil-Salom M; Sánchez MC; Chuan P; Clar F; Santamaría J; García-Sisamón F
    Eur Urol; 1990; 17(4):281-5. PubMed ID: 2364965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
    Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
    Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.
    Lapham RL; Grignon D; Ro JY
    Semin Diagn Pathol; 1997 May; 14(2):109-22. PubMed ID: 9179972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple biopsies of normal-looking urothelium in patients with superficial bladder cancer: Are they necessary?
    Fujimoto N; Harada S; Terado M; Sato H; Matsumoto T
    Int J Urol; 2003 Dec; 10(12):631-5. PubMed ID: 14633065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 28. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The presence of muscularis mucosae in the urinary bladder of samples from transurethral resection].
    Sánchez-Chapado M; Angulo Cuesta J
    Arch Esp Urol; 1995 Mar; 48(2):117-22. PubMed ID: 7755416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma.
    Pagano F; Garbeglio A; Milani C; Bassi P; Pegoraro V
    Eur Urol; 1987; 13(3):145-9. PubMed ID: 3609087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Iatrogenic tumor cell implantation in bladder cancer].
    Mack D; Rammal E; Jakse G
    Urologe A; 1988 Mar; 27(2):99-104. PubMed ID: 3376373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Verbeek AL; Debruyne FM
    J Urol; 1993 Jul; 150(1):60-4. PubMed ID: 8510276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy?
    Quilty PM; Hargreave TB; Smith G; Duncan W
    Br J Urol; 1987 Mar; 59(3):242-7. PubMed ID: 3567486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of random bladder biopsies in superficial bladder cancer.
    Göğüş C; Bedük Y; Türkölmez K; Göğüs O
    Int Urol Nephrol; 2002; 34(1):59-61. PubMed ID: 12549641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Squamous metaplasia as a prognostic factor in urothelial carcinoma of the bladder].
    Vecchioli Scaldazza C; Morosetti C
    Minerva Urol Nefrol; 1992; 44(2):97-100. PubMed ID: 1411869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of multiple biopsies of nontumorous bladder mucosa in patients with bladder cancer].
    Takahashi K; Sakashita S; Maru A; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):540-4. PubMed ID: 2747095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo detection by microscopic chromocystoscopy of concurrent urothelial atypia in superficial bladder cancer.
    Iguchi A; Kinoshita N; Masaki Z
    Br J Urol; 1992 Aug; 70(2):152-5. PubMed ID: 1393438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.